188 related articles for article (PubMed ID: 28470665)
41. Betulinic acid prevention of d-galactosamine/lipopolysaccharide liver toxicity is triggered by activation of Bcl-2 and antioxidant mechanisms.
Zheng ZW; Song SZ; Wu YL; Lian LH; Wan Y; Nan JX
J Pharm Pharmacol; 2011 Apr; 63(4):572-8. PubMed ID: 21401610
[TBL] [Abstract][Full Text] [Related]
42. Effect of tumor necrosis factor-α on the expression of the ammonia transporter Rhcg in the brain in mice with acute liver failure.
Wang W; Lu H; Lu X; Wang D; Wang Z; Dai W; Wang J; Liu P
J Neuroinflammation; 2018 Aug; 15(1):234. PubMed ID: 30134917
[TBL] [Abstract][Full Text] [Related]
43. Protective effect of SKLB010 against D-galactosamine/lipopolysaccharide-induced acute liver failure via nuclear factor-κB signaling pathway in macrophages.
Xie C; Jingjing W; Li X; Zeng F; Ma L; Li C; Wei Z; Peng A; Chen L
Int Immunopharmacol; 2014 Aug; 21(2):261-8. PubMed ID: 24861250
[TBL] [Abstract][Full Text] [Related]
44. Kaempferol protects mice from d-GalN/LPS-induced acute liver failure by regulating the ER stress-Grp78-CHOP signaling pathway.
Wang H; Chen L; Zhang X; Xu L; Xie B; Shi H; Duan Z; Zhang H; Ren F
Biomed Pharmacother; 2019 Mar; 111():468-475. PubMed ID: 30594786
[TBL] [Abstract][Full Text] [Related]
45. [Role of endoplasmic reticulum stress in D-GalN/LPS-induced acute liver failure].
Ren F; Yang B; Zhang X; Wen T; Wang X; Yin J; Piao Z; Zheng S; Zhang J; Chen Y; Chen D; Duan Z
Zhonghua Gan Zang Bing Za Zhi; 2014 May; 22(5):364-8. PubMed ID: 25180872
[TBL] [Abstract][Full Text] [Related]
46. Protective effects of Asiaticoside on acute liver injury induced by lipopolysaccharide/D-galactosamine in mice.
Zhang L; Li HZ; Gong X; Luo FL; Wang B; Hu N; Wang CD; Zhang Z; Wan JY
Phytomedicine; 2010 Aug; 17(10):811-9. PubMed ID: 20171071
[TBL] [Abstract][Full Text] [Related]
47. Echinacoside ameliorates D-galactosamine plus lipopolysaccharide-induced acute liver injury in mice via inhibition of apoptosis and inflammation.
Li X; Gou C; Yang H; Qiu J; Gu T; Wen T
Scand J Gastroenterol; 2014 Aug; 49(8):993-1000. PubMed ID: 24797709
[TBL] [Abstract][Full Text] [Related]
48. Complement and the alternative pathway play an important role in LPS/D-GalN-induced fulminant hepatic failure.
Sun S; Guo Y; Zhao G; Zhou X; Li J; Hu J; Yu H; Chen Y; Song H; Qiao F; Xu G; Yang F; Wu Y; Tomlinson S; Duan Z; Zhou Y
PLoS One; 2011; 6(11):e26838. PubMed ID: 22069473
[TBL] [Abstract][Full Text] [Related]
49. Hepatoprotective effect of 3-alkynyl selenophene on acute liver injury induced by D-galactosamine and lipopolysaccharide.
Wilhelm EA; Jesse CR; Roman SS; Nogueira CW; Savegnago L
Exp Mol Pathol; 2009 Aug; 87(1):20-6. PubMed ID: 19344711
[TBL] [Abstract][Full Text] [Related]
50. An inhibitor of c-Jun NH2-terminal kinase, SP600125, protects mice from D-galactosamine/lipopolysaccharide-induced hepatic failure by modulating BH3-only proteins.
Takamura M; Matsuda Y; Yamagiwa S; Tamura Y; Honda Y; Suzuki K; Ichida T; Aoyagi Y
Life Sci; 2007 Mar; 80(14):1335-44. PubMed ID: 17300814
[TBL] [Abstract][Full Text] [Related]
51. Tumor necrosis factor-induced toxic liver injury results from JNK2-dependent activation of caspase-8 and the mitochondrial death pathway.
Wang Y; Singh R; Lefkowitch JH; Rigoli RM; Czaja MJ
J Biol Chem; 2006 Jun; 281(22):15258-67. PubMed ID: 16571730
[TBL] [Abstract][Full Text] [Related]
52. Pretreatment with wortmannin alleviates lipopolysaccharide/d-galactosamine-induced acute liver injury.
Li Y; Wang X; Wei Z; Mao H; Gao M; Liu Y; Ma Y; Liu X; Guo C; Zhang L; Wang X
Biochem Biophys Res Commun; 2014 Dec; 455(3-4):234-40. PubMed ID: 25449276
[TBL] [Abstract][Full Text] [Related]
53. Protective mechanisms of acacetin against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure in mice.
Cho HI; Park JH; Choi HS; Kwak JH; Lee DU; Lee SK; Lee SM
J Nat Prod; 2014 Nov; 77(11):2497-503. PubMed ID: 25382719
[TBL] [Abstract][Full Text] [Related]
54. Suramin prevents fulminant hepatic failure resulting in reduction of lethality through the suppression of NF-kappaB activity.
Goto T; Takeuchi S; Miura K; Ohshima S; Mikami K; Yoneyama K; Sato M; Shibuya T; Watanabe D; Kataoka E; Segawa D; Endo A; Sato W; Yoshino R; Watanabe S
Cytokine; 2006 Jan; 33(1):28-35. PubMed ID: 16413198
[TBL] [Abstract][Full Text] [Related]
55. Transgenic expression of cyclooxygenase-2 in hepatocytes accelerates endotoxin-induced acute liver failure.
Han C; Li G; Lim K; DeFrances MC; Gandhi CR; Wu T
J Immunol; 2008 Dec; 181(11):8027-35. PubMed ID: 19017995
[TBL] [Abstract][Full Text] [Related]
56. Protective effects of luteolin against apoptotic liver damage induced by D-galactosamine/lipopolysaccharide in mice.
Lee WC; Jung HA; Choi JS; Kim YS; Lee SM
J Nat Prod; 2011 Sep; 74(9):1916-21. PubMed ID: 21899269
[TBL] [Abstract][Full Text] [Related]
57. Farnesyltransferase inhibitor, tipifarnib, prevents galactosamine/lipopolysaccharide-induced acute liver failure.
Shirozu K; Hirai S; Tanaka T; Hisaka S; Kaneki M; Ichinose F
Shock; 2014 Dec; 42(6):570-577. PubMed ID: 25046541
[TBL] [Abstract][Full Text] [Related]
58. Etoposide prevents apoptosis in mouse liver with D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality.
Nakama T; Hirono S; Moriuchi A; Hasuike S; Nagata K; Hori T; Ido A; Hayashi K; Tsubouchi H
Hepatology; 2001 Jun; 33(6):1441-50. PubMed ID: 11391533
[TBL] [Abstract][Full Text] [Related]
59. Mechanism for hepato-protective action of Liangxue Huayu Recipe (LHR): blockade of mitochondrial cytochrome c release and caspase activation.
Jiang ZQ; Yan XJ; Bi L; Chen JP; Zhou Q; Chen WP
J Ethnopharmacol; 2013 Jul; 148(3):851-60. PubMed ID: 23711831
[TBL] [Abstract][Full Text] [Related]
60. Protective effects of agmatine against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure in mice.
El-Agamy DS; Makled MN; Gamil NM
Inflammopharmacology; 2014 Jun; 22(3):187-94. PubMed ID: 23989863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
